Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
287,3 SEK | +7,85% | +9,56% | +6,44% |
Vakgebied
Aantal werknemers: 1 772
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Haematology
60,4
%
| 10 831 | 57,6 % | 13 370 | 60,4 % | +23,44% |
Immunology
34,5
%
| 6 679 | 35,5 % | 7 635 | 34,5 % | +14,31% |
Specialty Care
5,1
%
| 1 280 | 6,8 % | 1 119 | 5,1 % | -12,58% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
36,8
%
| 7 364 | 39,2 % | 8 148 | 36,8 % | +10,65% |
Europe
35,5
%
| 3 585 | 19,1 % | 7 851 | 35,5 % | +119,00% |
Global
12,3
%
| 1 427 | 7,6 % | 2 718 | 12,3 % | +90,47% |
Rest of the World
12,0
%
| 2 438 | 13,0 % | 2 653 | 12,0 % | +8,82% |
Sweden
3,0
%
| 667 | 3,5 % | 660 | 3,0 % | -1,05% |
North America
0,4
%
| 77 | 0,4 % | 93 | 0,4 % | +20,78% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 59 | 22-05-17 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 57 | 20-07-18 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | 49 | 01-01-10 | |
Sven Ullman
BRD | Director/Board Member | 68 | 01-01-21 |
Pablo de Mora
SAM | Sales & Marketing | 56 | 01-01-19 |
Daniel Rankin
PRN | Corporate Officer/Principal | 44 | 01-01-17 |
Mahmood Ladha
PRN | Corporate Officer/Principal | 60 | 01-01-19 |
Norbert Oppitz
PRN | Corporate Officer/Principal | 57 | 02-10-17 |
Armin Reininger
PRN | Corporate Officer/Principal | 67 | 06-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sven Ullman
BRD | Director/Board Member | 68 | 01-01-21 |
Annette Clancy
CHM | Chairman | 70 | 08-05-14 |
Staffan Schüberg
BRD | Director/Board Member | 55 | 01-01-20 |
Director/Board Member | 54 | 05-05-11 | |
Filippa Stenberg
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 621 178 | 0 | 1 621 178 ( 100,00 %) | 50,87 % |
Aandeel B | 1 | 354 358 946 | 181 069 759 ( 51,10 %) | 14 601 832 ( 4,121 %) |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
14 436 902 | 4.07% | 360 767 353 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,44% | 8,31 mld. | |
-2,86% | 87,31 mld. | |
+3,95% | 40,86 mld. | |
-21,94% | 29,36 mld. | |
+56,53% | 24,49 mld. | |
-5,41% | 17,31 mld. | |
-44,23% | 11,26 mld. | |
-17,60% | 11,62 mld. | |
-13,96% | 11,31 mld. | |
+2,09% | 7,63 mld. |
- Beurs
- Aandelen
- Koers SOBI
- Onderneming Swedish Orphan Biovitrum AB